India to Australia: Simvastatin Export Trade Route
India has recorded 168 verified shipments of Simvastatin exported to Australia, representing a combined trade value of $3.9M USD. This corridor is served by 9 active Indian exporters, with an average shipment value of $23.1K USD. The leading Indian exporter is TORRENT PHARMACEUTICALS LTD, which accounts for 32% of total export value with 20 shipments worth $1.2M USD. On the buying side, APOTEX PTY LIMITED is the largest importer in Australia with $763.2K USD in purchases. The top 3 suppliers — TORRENT PHARMACEUTICALS LTD, CIPLA LIMITED, TORRENT PHARMACEUTICALS LIMITED — together control 70% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Australia Simvastatin corridor is one of India's established pharmaceutical export routes, with 168 shipments documented worth a combined $3.9M USD. The route is dominated by TORRENT PHARMACEUTICALS LTD, which alone accounts for roughly 32% of all export value, reflecting the consolidated nature of India's simvastatin manufacturing sector.
Across 9 active suppliers, the average shipment value stands at $23.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with simvastatin's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 27.6%, placing it at rank #10 among India's top simvastatin export destinations globally.
On the import side, key buyers of Indian simvastatin in Australia include APOTEX PTY LIMITED, ARROW PHARMACEUTICALS PTY LTD, APOTEX AUSTRALIA and 24 others. APOTEX PTY LIMITED is the single largest importer with 13 shipments valued at $763.2K USD.
Route Characteristics
- Average transit30 days
- Peak seasonQ4
- Primary modeSea freight
- Top portNHAVA SHEVA SEA (INNSA1)
Market Position
- Global rank#10
- Annual growth+27.6%
- Demand growth+23.2%
- Regulatory ease78/100
Top 10 Indian Simvastatin Exporters to Australia
Showing top 10 of 9 Indian suppliers exporting Simvastatin to Australia, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TORRENT PHARMACEUTICALS LTD Avg $61.9K per shipment | 20 | $1.2M | 31.8% |
| 2 | CIPLA LIMITED Avg $14.0K per shipment | 70 | $977.6K | 25.2% |
| 3 | TORRENT PHARMACEUTICALS LIMITED Avg $56.5K per shipment | 9 | $508.5K | 13.1% |
| 4 | MYLAN LABORATORIES LIMITED Avg $24.3K per shipment | 15 | $364.1K | 9.4% |
| 5 | BAFNA PHARMACEUTICALS LIMITED Avg $16.4K per shipment | 18 | $295.7K | 7.6% |
| 6 | CIPLA LIMITED Avg $10.6K per shipment | 23 | $244.6K | 6.3% |
| 7 | TORRENT PHARMACEUTICALS LTD Avg $56.5K per shipment | 3 | $169.5K | 4.4% |
| 8 | MYLAN LABORATORIES LIMITED Avg $16.9K per shipment | 5 | $84.6K | 2.2% |
| 9 | ALKEM LABORATORIES LIMITED Avg $1.0K per shipment | 5 | $5.2K | 0.1% |
This table shows the top 10 of 9 Indian companies exporting simvastatin to Australia, ranked by total trade value. The listed exporters are: TORRENT PHARMACEUTICALS LTD, CIPLA LIMITED, TORRENT PHARMACEUTICALS LIMITED, MYLAN LABORATORIES LIMITED, BAFNA PHARMACEUTICALS LIMITED, CIPLA LIMITED , TORRENT PHARMACEUTICALS LTD , MYLAN LABORATORIES LIMITED , ALKEM LABORATORIES LIMITED. TORRENT PHARMACEUTICALS LTD is the dominant supplier with 20 shipments worth $1.2M USD, giving it a 32% market share. The top 3 suppliers together account for 70% of the total trade value on this route.
Top 10 Simvastatin Importers in Australia
Showing top 10 of 27 known buyers in Australia receiving Simvastatin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian simvastatin in Australia include APOTEX PTY LIMITED, ARROW PHARMACEUTICALS PTY LTD, APOTEX AUSTRALIA, ARROW PHARMACEUTICALS PTY LIMITED, ARROW PHARMACEUTICALS PTY LTD., among 27 total buyers. The largest importer is APOTEX PTY LIMITED, accounting for $763.2K USD across 13 shipments — representing 20% of all simvastatin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | APOTEX PTY LIMITED | 13 | $763.2K | 19.6% |
| 2 | ARROW PHARMACEUTICALS PTY LTD | 28 | $744.2K | 19.1% |
| 3 | APOTEX AUSTRALIA | 48 | $487.1K | 12.5% |
| 4 | ARROW PHARMACEUTICALS PTY LIMITED | 10 | $317.8K | 8.2% |
| 5 | ARROW PHARMACEUTICALS PTY LTD. | 4 | $185.6K | 4.8% |
| 6 | APOTEX PTY LTD. | 2 | $170.9K | 4.4% |
| 7 | ALPHAPHARM PTY LTD | 5 | $157.7K | 4.1% |
| 8 | APOTEX AUSTRALIA | 13 | $148.9K | 3.8% |
| 9 | APOTEX PTY LTD | 1 | $110.5K | 2.8% |
| 10 | ALPHAPHARM PTY LIMITED | 3 | $100.7K | 2.6% |
Showing top 10 of 27 Simvastatin importers in Australia on this route.
Top 10 Simvastatin Formulations Imported by Australia
Showing top 10 of 127 product formulations shipped on the India to Australia Simvastatin route, ranked by trade value
Australia imports a wide range of simvastatin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — SIMVAR 80 TABLET(SIMVASTATIN 80MG)(9264PACKS X6X5S= 277920NOS) — accounts for $317.8K USD across 1 shipments. There are 127 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SIMVAR 80 TABLET(SIMVASTATIN 80MG)(9264PACKS X6X5S= 277920NOS) | 1 | $317.8K | 8.2% |
| 2 | OTHERS : APO-EZETIMIBE/SIMVASTATIN 10/80 | 2 | $212.4K | 5.5% |
| 3 | "OTHERS"- PHARMA : APO-EZETIMIBE/SIMVASTATIN 10/20 TABLETS EZETIMIBE 10MG+SIMVASTATIN 20MG - 01 NOS = SIZE 3x10 TABS | 3 | $199.1K | 5.1% |
| 4 | SIMVASTATIN TABLETS 80 MG PACKS 8500'SBSP | 2 | $119.9K | 3.1% |
| 5 | EZETORIN 10/80 TABLETS(EZETIMIBE 10MG AND SIMVASTATIN 80MG)B.NO.BJR4M001,BJR4M002,MFG:JAN-2025,EXP:DEC-2026 | 1 | $117.8K | 3.0% |
| 6 | APO-EZETIMIBE/SIMVASTATIN 10/80 TABLETSEZETIMIBE 10MG AND SIMVASTATIN 80MG TABLETS NOS = 3X10 TAB | 1 | $116.5K | 3.0% |
| 7 | EZETORIN 10/80 TABLETS EZETIMIBE 10MG AND SIMVASTATIN 80MG NOS 3X10 TABLETS | 2 | $113.4K | 2.9% |
| 8 | OTHERS : EZSIMVAGH 10/40 TABLETS (EZETIMIBE 10MG + SIMVASTATIN 40MG) - 01 NOS =SIZE 3x10 TABS | 1 | $90.2K | 2.3% |
| 9 | APO-EZETIMIBE/SIMVASTATIN 10/40 TABLETS | 1 | $74.2K | 1.9% |
| 10 | OTHERS : APO-EZETIMIBE/SIMVASTATIN 10/40TABLETS EZETIMIBE 10MG+SIMVASTATIN 40MG - 1 NOS = SIZE 3 X 10 TABS | 1 | $73.0K | 1.9% |
Showing top 10 of 127 Simvastatin formulations imported by Australia on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 76%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
NHAVA SHEVA SEA (INNSA1) handles the highest volume with 45 shipments. Transit time averages 30 days by sea.
Market Dynamics
India's simvastatin exports to Australia are driven primarily by a handful of large-scale manufacturers. TORRENT PHARMACEUTICALS LTD with 20 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 9 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — TORRENT PHARMACEUTICALS LTD, CIPLA LIMITED, TORRENT PHARMACEUTICALS LIMITED — together account for 70% of total trade value on this route. The average shipment value of $23.1K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as others : apo-ezetimibe/simvastatin 10/80 and "others"- pharma : apo-ezetimibe/simvastatin 10/20 tablets ezetimibe 10mg+simvastatin 20mg - 01 nos = size 3x10 tabs, suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, APOTEX PTY LIMITED is the largest importer with 13 shipments worth $763.2K USD — representing 20% of all simvastatin imports from India on this route. A total of 27 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $3.9M
- Avg. Shipment
- $23.1K
- Suppliers
- 9
- Buyers
- 27
- Transit (Sea)
- ~30 days
- Annual Growth
- +27.6%
Related Analysis
Other Simvastatin Routes
Unlock the Full India to Australia Simvastatin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 168 shipments on this route.
Frequently Asked Questions — India to Australia Simvastatin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Simvastatin to Australia?
The leading Indian exporters of Simvastatin to Australia are TORRENT PHARMACEUTICALS LTD, CIPLA LIMITED, TORRENT PHARMACEUTICALS LIMITED. TORRENT PHARMACEUTICALS LTD holds the largest market share at approximately 32% of total trade value on this route.
Q What is the total value of Simvastatin exports from India to Australia?
India exports Simvastatin to Australia worth approximately $3.9M USD across 168 recorded shipments. The average value per shipment is $23.1K USD.
Q Which ports does India use to ship Simvastatin to Australia?
The most active port of origin is NHAVA SHEVA SEA (INNSA1) with 45 shipments. Indian exporters primarily use sea freight for this route, with 76% of shipments going by sea and 23% by air.
Q How long does shipping take from India to Australia for Simvastatin?
The average transit time for Simvastatin shipments from India to Australia is approximately 30 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Australia Simvastatin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 27.6% with demand growth tracking at 23.2%. The route is ranked #10 among India's top Simvastatin export destinations globally.
Q How many suppliers are active on the India to Australia Simvastatin route?
There are currently 9 active Indian suppliers exporting Simvastatin to Australia. The market is moderately concentrated with TORRENT PHARMACEUTICALS LTD accounting for 32% of total shipment value.
Q Who are the main importers of Simvastatin from India in Australia?
The leading importers of Indian Simvastatin in Australia include APOTEX PTY LIMITED, ARROW PHARMACEUTICALS PTY LTD, APOTEX AUSTRALIA, ARROW PHARMACEUTICALS PTY LIMITED, ARROW PHARMACEUTICALS PTY LTD.. APOTEX PTY LIMITED is the largest buyer with 13 shipments worth $763.2K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Australia export trade corridor identified from Indian Customs (DGFT) records for Simvastatin.
- 2.Supplier/Buyer Matching: 9 Indian exporters and 27 importers in Australia matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 168 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
168 Verified Shipments
9 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists